This map shows the geographic impact of C S Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C S Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C S Johnson more than expected).
This network shows the impact of papers produced by C S Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C S Johnson. The network helps show where C S Johnson may publish in the future.
Co-authorship network of co-authors of C S Johnson
This figure shows the co-authorship network connecting the top 25 collaborators of C S Johnson.
A scholar is included among the top collaborators of C S Johnson based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with C S Johnson. C S Johnson is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
13 of 13 papers shown
1.
Vogt, Andreas, et al.. (2000). In vivo antitumor activity and induction of insulin-like growth factor-1-resistant apoptosis by SC-alphaalphadelta9.. PubMed. 292(2). 530–7.3 indexed citations
2.
Smith, David C., et al.. (1999). A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.. PubMed. 5(6). 1339–45.135 indexed citations
3.
Hoyt, Dale G., James M. Rusnak, Robert Mannix, et al.. (1996). Integrin activation suppresses etoposide-induced DNA strand breakage in cultured murine tumor-derived endothelial cells.. PubMed. 56(18). 4146–9.45 indexed citations
4.
Chang, Minmin, et al.. (1996). Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.. PubMed. 56(4). 886–91.10 indexed citations
5.
Yu, Weidong, et al.. (1992). Differential effect in vitro of tumor necrosis factor-alpha (TNF) on normal and virus-infected erythroid progenitors from Friend virus (FVA)-infected mice.. PubMed. 20(11). 1271–7.2 indexed citations
Johnson, C S, et al.. (1991). Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.. PubMed. 19(2). 101–5.24 indexed citations
Adlakha, Arun, et al.. (1990). In vitro studies on the mechanism of action of hepsulfam in chronic myelogenous leukemia patients.. PubMed. 50(23). 7559–63.18 indexed citations
10.
Constantinidis, Ioannis, Paul G. Braunschweiger, Janna P. Wehrle, et al.. (1989). 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.. PubMed. 49(22). 6379–82.26 indexed citations
11.
Braunschweiger, Paul G., et al.. (1988). Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.. PubMed. 48(21). 6011–6.51 indexed citations
Johnson, C S, John F. Marcelletti, Clifford Longley, & Philip Furmanski. (1982). Inhibition of normal erythropoiesis in mice with Friend virus induced erythroleukemia.. PubMed. 10(9). 743–53.8 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.